Mylan NV, has accused Teva Pharmaceutical Industries Ltd. for the Violation of U.S. Anti-trust Rules, in an acquisition deal.
Teva disclosed a 1.35 percent stake in Mylan last week. Furthermore, The violated rule is not yet clarified by Mylan.
View the full release here.